Join KBI Biopharma, Inc. at BIO Korea! Be sure to stop by our booth to meet with Toshihiro Ogawa, Senior Director of Business Development.
KBI Biopharma is a leading global contract development and manufacturing organization (CDMO) providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. With each of our 500+ client partners, we work closely to personalize and accelerate drug development programs. Built upon a foundation of world-class analytics capabilities and extensive scientific and technical expertise, we deliver robust process development and clinical and commercial cGMP manufacturing services for mammalian, microbial, and cell therapy programs. Recognized for quality manufacturing, we help clients advance drug candidates into the clinic and beyond.
Since 2006, BIO KOREA has been holding the International Convention every year for invigorating and growing the global bio-health industry. This year also, we are pleased to announce the 18th BIO KOREA will be held on May 10-12, 2023 at COEX, Seoul. Through various programs of BIO KOREA 2023 including Conferences, Business Partnering, Exhibition, and Invest Fair, exchange the newest bio-health trends and technology as well as get the global expansion business opportunity with various international academics, professionals, and CEOs of the global bio-health field!